Treatment Outcomes With Pegylated Interferon and Ribavirin for Male Prisoners With Chronic Hepatitis C: Erratum.1
The article appearing on page 686 of the August issue of the Journal of Clinical Gastroenterology had incorrect information. In table 2, the results for GT 1 CA and GT 1 AA SVR were reversed. GT 1 CA SVR should be 18% and GT 1 AA SVR should be 22%.
This error has been noted in the online version of the article, which is available at www.jcge.com.
© 2009 Lippincott Williams & Wilkins, Inc.
1. 1. Qi W, Chu J, Zhou D, et al. Characterization and applications of a newly developed rabbit monoclonal antibody to cytokeratin 7 (CK7) for immunohistochemistry. Appl Immunohistochem Mol Morphol. 2009;17:233–238.